S'abonner

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies - 10/08/11

Doi : 10.1016/j.jaci.2010.10.027 
Marija Geroldinger-Simic, MD a, Thomas Zelniker, MD a, Werner Aberer, MD c, Christof Ebner, MD d, Cornelia Egger, MD e, Antonia Greiderer e, Nicole Prem, MD c, Jonas Lidholm, PhD f, Barbara K. Ballmer-Weber, MD g, Stefan Vieths, PhD h, Barbara Bohle, PhD a, b,
a Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria 
b Christian Doppler Laboratory for Immunomodulation, Medical University of Vienna, Vienna, Austria 
c University Clinic for Dermatology, Medical University of Graz, Graz, Austria 
d Allergy Clinic Reumannplatz, Vienna, Austria 
e Department of Dermatology, University Clinic Innsbruck, Innsbruck, Austria 
f Research and Development Department, Phadia AB, Uppsala, Sweden 
g Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland 
h Paul-Ehrlich-Institut, Division of Allergology, Langen, Germany 

Reprint requests: Barbara Bohle, PhD, Medical University of Vienna, Department of Pathophysiology and Allergy Research, Waehringer Guertel 18-20, AKH-3Q, A-1090 Wien, Austria.

Abstract

Background

Patients with birch pollen allergy often develop allergic reactions to plant foods.

Objective

To evaluate the prevalence, main symptoms, and triggers of birch pollen–related food allergy and the role of food-specific IgG4 antibodies in food tolerance.

Methods

Food-induced symptoms were evaluated in 225 individuals with birch pollen allergy by using a standardized questionnaire. IgE and IgG4 levels specific for the major birch pollen allergen Bet v 1 and birch profilin Bet v 2 and the Bet v 1 homologs in apple (Mal d 1) and hazelnut (Cor a 1) were quantified by ImmunoCAP. Mock-treated and IgG-depleted sera from patients tolerating hazelnuts in food challenges were compared for their inhibitory activity for binding of Cor a 1–IgE complexes to B cells.

Results

In total, 73% of the study population experienced food allergy, which was perennial in 86% of the affected individuals. The oral allergy syndrome was the main clinical manifestation. However, more than 58% of the patients also experienced food-induced rhinoconjunctivitis. Apples and hazelnuts were identified as the most frequent triggers. Food allergy correlated with IgE reactivity to Bet v 1 but not to Bet v 2. Mal d 1–specific and Cor a 1–specific IgG4/IgE ratios were significantly higher in food-tolerant individuals than individuals with food allergy. Sera from IgG4-positive food-tolerant patients possessed IgG-dependent IgE-inhibitory activity.

Conclusion

Birch pollen–related food allergy is highly prevalent and often perennial. High food allergen–specific IgG4/IgE ratios seem associated with food tolerance, potentially because specific IgG4 blocks IgE binding to food allergens. Thus, the presence of food allergen–specific IgG4 antibodies is no diagnostic marker for birch pollen–related food allergy.

Le texte complet de cet article est disponible en PDF.

Key words : Birch pollen allergy, food allergy, oral allergy syndrome, Bet v 1, IgE, blocking antibodies

Abbreviations used : FAB, r, SIT


Plan


 Supported by the Austrian Science Fund, project SFB-F1807-B13, the Christian Doppler Research Association, and Biomay AG, Vienna, Austria.
 Disclosure of potential conflict of interest: B. Bohle receives research support from the Austrian Science Fund and the Christian Doppler Laboratory. S. Vieths is an associate for the Institute for Product Quality; has received honoraria for scientific presentations from Phadia; has received honoraria as an expert reviewer from the Food Allergy Resource and Research Program; has received research support from the European Union, the German Research Foundation, the German Federal Ministry of Education and Research, the Research Fund for the German Food Industry, Monsanto Co, Pioneer Hi-Bred International, Inc, the Food Allergy Resource and Research Program, and the European Directorate for the Quality of Medicines and Health Care; is chairman of the Food Allergy Interest Group and a member of the Executive Committee for EAACI; is chairman of the Allergen Standardization Subcommittee and secretary of the Allergen Nomenclature Subcommittee for the International Union of Immunological Studies; is a Registered Expert for the European Agency for the Evaluation of Medicinal Products and European Pharmacopoeia Commission; is chairman of Technical Committee 275 Working Group 12 “Food Allergens” for the European Committee for Standardization; and is a member of the Food Allergy Working Group for the German Society for Allergy and Clinical Immunology. The rest of the authors have declared that they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 127 - N° 3

P. 616 - mars 2011 Retour au numéro
Article précédent Article précédent
  • Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic
  • Sara R. Prickett, Astrid L. Voskamp, April Dacumos-Hill, Karen Symons, Jennifer M. Rolland, Robyn E. O’Hehir
| Article suivant Article suivant
  • Incidence, prevalence, and trends of general practitioner–recorded diagnosis of peanut allergy in England, 2001 to 2005
  • Daniel Kotz, Colin R. Simpson, Aziz Sheikh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.